Clinical Chemistry Podcast · Association for Diagnostics and Laboratory Medicine

Transdermal GFR Signals a New Horizon in Renal Diagnostics

·12 min·1 clip

A new FDA-approved device could detect kidney disease in millions who don't know they have it.

This episode discusses transdermal GFR (TGFR), a new FDA-approved device for monitoring kidney function without serial blood draws. Dr. Raj Punja explains how the MediBeacon system works, compares TGFR to traditional methods, and highlights its benefits and limitations, including potential interference with laboratory tests.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Clinical Chemistry Podcast